With goal of improving patients’ overall care, Pittsburgh-based pharmacy is aiming to be licensed in all 50 states.
Pittsburgh is now home to a new specialty pharmacy: Zeal. The pharmacy was initially licensed in March of this year, and can now dispense to patients nationwide, with the receipt of non-resident licensure. The pharmacy is currently licensed to operate in 45 states, with the remainder in process and expected by Q4.
Zeal is also in-process and scheduled for survey for accreditation through both URAC and the Accreditation Commission for Health Care (ACHC) for specialty pharmacy and rare disease designations.
That technology features web-based patient management platforms that allows the Zeal team to customize the patient journey for each patient, based on their clinical presentation and needs. Patients may elect multiple modes of communication with their clinical team, including text and email, and can leverage smart device technology in their homes to enhance the overall care needed to manage their specialty diagnosis.
" … It is our goal to manage multiple rare disease medications through our first-in-class care model, building our own ‘zeal’ of support for these traditionally underrepresented patients,” says Brenden Harper, CFO and co-founder.